Heart:中国东北地区房颤的流行病学特征

2019-10-15 xing.T MedSci原创

由此可见,东北地区的AF负担巨大,OAC治疗的未充分使用和合并症未能有效控制可能会在未来几十年中加剧AF患者的心血管结局。对于东北地区急需AF及相关危险因素长期管理的策略。

近日,心脏病领域权威杂志Heart上发表了一篇研究文章,这项研究旨在评估中国东北地区房颤流行病学特征。

该研究采用多阶段、分层和整群随机抽样方法,于2017年9月至2019年3月在辽宁省进行了横断面调查。共有18796名(28.9%城市居民,71.1%农村居民)年龄≥40岁的参与者被纳入研究。所有参与者均填写了问卷,并接受了身体检查和心电图检查。根据病史和心电图检查诊断房颤

房颤总患病率为1.1%。随着年龄的增长急剧增加。房颤在男性中比女性更为普遍(1.5% vs. 0.9%,p<0.001);然而,城乡之间的差异并不显著(1.3% vs. 1.1%,p=0.228)。在AF人群中,总体AF意识为52.6%,女性高于男性(61.5% vs. 44.1%,p=0.011);但是,区域之间的差异没有统计学意义(60.0% vs. 49.0%,p=0.129)。根据CHA2DS-VASc评分,几乎所有受试者(90.2%,194/215)都需要口服抗凝(OAC)治疗。但是,只有4.1%的人接受了OAC治疗。此外,AF患者中高血压(66.5%)、血脂异常(32.6%)和糖尿病(24.2%)患病率高,但控制率却低得令人无法接受(分别为7.0%、8.6%和28.8%)。

由此可见,东北地区的AF负担巨大,OAC治疗的未充分使用和合并症未能有效控制可能会在未来几十年中加剧AF患者的心血管结局。对于东北地区急需AF及相关危险因素长期管理的策略。 

原始出处:

Liying Xing.et al.Epidemiology of atrial fibrillation in northeast China: a cross-sectional study, 2017–2019.heart.2019.http://dx.doi.org/10.1136/heartjnl-2019-315397

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2033133, encodeId=1402203313339, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sat Dec 21 19:39:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374375, encodeId=aae13e4375fc, content=写的真好, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:16:44 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357287, encodeId=b240135e2870b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411330, encodeId=b6e81411330d6, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563158, encodeId=c78a1563158b8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373947, encodeId=d1443e394795, content=防治怎么办?, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Oct 15 09:33:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2033133, encodeId=1402203313339, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sat Dec 21 19:39:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374375, encodeId=aae13e4375fc, content=写的真好, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:16:44 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357287, encodeId=b240135e2870b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411330, encodeId=b6e81411330d6, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563158, encodeId=c78a1563158b8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373947, encodeId=d1443e394795, content=防治怎么办?, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Oct 15 09:33:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    写的真好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2033133, encodeId=1402203313339, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sat Dec 21 19:39:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374375, encodeId=aae13e4375fc, content=写的真好, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:16:44 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357287, encodeId=b240135e2870b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411330, encodeId=b6e81411330d6, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563158, encodeId=c78a1563158b8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373947, encodeId=d1443e394795, content=防治怎么办?, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Oct 15 09:33:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
    2019-10-16 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=2033133, encodeId=1402203313339, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sat Dec 21 19:39:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374375, encodeId=aae13e4375fc, content=写的真好, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:16:44 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357287, encodeId=b240135e2870b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411330, encodeId=b6e81411330d6, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563158, encodeId=c78a1563158b8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373947, encodeId=d1443e394795, content=防治怎么办?, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Oct 15 09:33:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
    2019-10-16 xugumin
  5. [GetPortalCommentsPageByObjectIdResponse(id=2033133, encodeId=1402203313339, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sat Dec 21 19:39:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374375, encodeId=aae13e4375fc, content=写的真好, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:16:44 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357287, encodeId=b240135e2870b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411330, encodeId=b6e81411330d6, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563158, encodeId=c78a1563158b8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373947, encodeId=d1443e394795, content=防治怎么办?, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Oct 15 09:33:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
    2019-10-16 slcumt
  6. [GetPortalCommentsPageByObjectIdResponse(id=2033133, encodeId=1402203313339, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Sat Dec 21 19:39:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374375, encodeId=aae13e4375fc, content=写的真好, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 10:16:44 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357287, encodeId=b240135e2870b, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411330, encodeId=b6e81411330d6, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563158, encodeId=c78a1563158b8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Oct 16 22:39:00 CST 2019, time=2019-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373947, encodeId=d1443e394795, content=防治怎么办?, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Tue Oct 15 09:33:00 CST 2019, time=2019-10-15, status=1, ipAttribution=)]
    2019-10-15 flysky120

    防治怎么办?

    0

相关资讯

Clinica Chimica Acta:中国抗磷脂综合征患者非标准抗体的临床表现

越来越多的证据表明,非标准aPLs可在APS中作为现行标准aPLs的重要补充。在本研究中,研究人员评估了一组对磷脂抗原的非标准抗体,包括磷脂酰丝氨酸(aPS)、磷脂酰肌醇(aPI)、鞘磷脂(aSM)、磷脂酰胆碱(aPC)和磷脂酰乙醇胺(aPE)在明确的中国aPS队列中的临床表现。

中国的药品批量购买计划已经扩大,该计划促使部分药物价格下降超过90%

国内已将试点药物批量购买计划扩大到几乎整个国家,试图通过谈判降低药品制造商的价格。这给跨国制药公司及其国内竞争对手增加了压力。该计划于去年推出,共有11个城市共同合作批量购买25种药物。这导致一些药物的价格下降超过90%。

European Journal of Human Genetics:中国SNHL患者的综合遗传测试和变异解释

遗传性听力损失是一种单基因遗传病,并且具有高度的异质性。不少于100个耳聋基因在病理发生过程中具有作用。最近,有研究人员评估了SNVs在已知的耳聋基因中的比例,从而对中国散发性和家族性感感觉神经性耳聋患者的病因进行解释。研究人员手搜集了1127名个体的DNA样本,包括616名正常听力的健康对照,433名散发性SNHL患者和来源于30个听力损失谱系的78名耳聋患者。NGS测试包括了129个基因中的序

着力构建新型卫生健康服务体系 服务健康中国建设

新中国走过了70年的光辉历程,创造了无数人间奇迹,取得了举世瞩目的巨大成就,人民健康水平也得到了显着提高。到2018年,我国居民人均期望寿命接近77岁,婴儿死亡率、孕产妇死亡率分别下降到6.1/‰、18.3/10万,达到或接近中高收入国家水平。经过几十年的建设和发展,我国建立了与经济社会发展水平和人民群众日益增长健康需求比较适应、世界上规模最大、水平较高的卫生健康服务体系,在保障人民健康的伟大

提出中国高血压防控的四个独特方法:在公共场所建立可与微信链接的血压计,每年测量数千万人

上海交通大学医学院附属瑞金医院王继光教授介绍了中国高血压防控的独特途径。根据中国2012-2015年度全国高血压调查,成人高血压患病率为27.9%,较2002(18.8%)增加50%。高血压的知晓率、治疗率和控制率分别为46.9%、40.7%和15.3%。王继光指出,我国的高血压的管理水平有所提高,但仍处于较低水平,我国高血压管理面临的挑战仍然是低知晓率和低控制率。